Stockscreener 앱 받기
478.80
1.46%
6.895
전일 마감가:
$471.90
열려 있는:
$471.9
하루 거래량:
615.16K
Relative Volume:
0.75
시가총액:
$35.17B
수익:
$3.90B
순이익/손실:
$887.87M
주가수익비율:
44.87
EPS:
10.67
순현금흐름:
$798.08M
1주 성능:
+10.33%
1개월 성능:
+21.61%
6개월 성능:
+15.10%
1년 성능:
-0.37%
1일 변동 폭
$466.74
$478.94
1주일 범위
$428.09
$483.91
52주 변동 폭
$356.14
$548.88
아이덱스 래버러토리스 Stock (IDXX) Company Profile
명칭
Idexx Laboratories Inc
전화
(207) 556-0300
주소
ONE IDEXX DRIVE, WESTBROOK, ME
IDXX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
478.72 | 35.17B | 3.90B | 887.87M | 798.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
423.19 | 159.05B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
198.94 | 140.21B | 23.82B | 3.77B | 4.90B | 5.15 |
|
A
Agilent Technologies Inc
|
109.11 | 30.47B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
153.75 | 26.47B | 15.41B | 1.37B | 2.11B | 7.50 |
아이덱스 래버러토리스 Stock (IDXX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-30 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-12-04 | 업그레이드 | Cleveland Research | Neutral → Buy |
| 2023-08-02 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2022-07-21 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2022-05-05 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-08 | 개시 | Atlantic Equities | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-12 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-02-17 | 개시 | Barclays | Overweight |
| 2019-09-09 | 개시 | Goldman | Neutral |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2018-11-02 | 재확인 | BofA/Merrill | Buy |
| 2018-05-07 | 재확인 | Stifel | Buy |
| 2018-01-16 | 개시 | Piper Jaffray | Overweight |
| 2017-08-23 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | 업그레이드 | CL King | Neutral → Buy |
| 2017-02-03 | 다운그레이드 | Feltl & Co. | Hold → Sell |
| 2016-09-29 | 재개 | BofA/Merrill | Neutral |
| 2016-08-16 | 재확인 | Stifel | Buy |
| 2016-08-03 | 업그레이드 | Northcoast | Sell → Neutral |
| 2016-07-20 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-19 | 재확인 | Canaccord Genuity | Buy |
| 2016-04-01 | 개시 | CL King | Neutral |
| 2016-03-21 | 재확인 | Stifel | Buy |
| 2016-02-04 | 개시 | Credit Suisse | Outperform |
| 2015-10-29 | 재확인 | Stifel | Buy |
| 2015-08-28 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | 재확인 | Stifel | Buy |
| 2015-07-23 | 재확인 | Canaccord Genuity | Buy |
모두보기
아이덱스 래버러토리스 주식(IDXX)의 최신 뉴스
IDEXX Laboratories (IDXX) Target Price Raised by Morgan Stanley | IDXX Stock News - GuruFocus
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating - marketscreener.com
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript - Insider Monkey
Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500 - marketscreener.com
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid ... - Yahoo Finance
IDEXX Laboratories Inc (IDXX) Q1 2025 Earnings Call Highlights: Strong Organic Growth Amid Market Challenges - GuruFocus
IDEXX Laboratories Reports Strong Q1 2025 Results - TipRanks
IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Compensation Looks Acceptable To Us And Here's Why - simplywall.st
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
IDEXX Lab jumps after Q1 beat and guidance raise - MSN
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo Finance
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Following Q1 Results | IDXX Stock News - GuruFocus
IDEXX Laboratories (IDXX) Surges After Lifting 2025 Outlook on F - GuruFocus
IDEXX Laboratories stock jumps on Q1 beat (IDXX:NASDAQ) - Seeking Alpha
IDEXX Laboratories (IDXX) Reports Strong Start to 2025 with Reve - GuruFocus
IDEXX Laboratories Ups Profit Forecast Thanks To Pet Care Demand - Finimize
Earnings call transcript: IDEXX Labs Q1 2025 EPS beats forecast, stock surges - Investing.com
IDXX Q1 Earnings Beat, FY25 View Raised, Stock Up in Pre-Market - TradingView
Does IDEXX Laboratories (NASDAQ:IDXX) Deserve A Spot On Your Watchlist? - Yahoo Finance
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics - marketscreener.com
IDEXX (IDXX) Reports Q1 Revenue Exceeding Expectations | IDXX St - GuruFocus
IDEXX Laboratories Q1 Earnings, Revenue Increase; 2025 Outlook Raised - marketscreener.com
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates - Nasdaq
Idexx: Q1 Earnings Snapshot - MySA
IDEXX Laboratories (IDXX) Surpasses Q1 Expectations with Robust Earnings - GuruFocus
IDEXX Laboratories Announces First Quarter Results | IDXX Stock News - GuruFocus
IDEXX Laboratories Q1 2025 Earnings: EPS of $2.96 Beats Estimate - GuruFocus
IDEXX Laboratories Inc Q1 Profit Advances, Beats Estimates - Nasdaq
IDEXX LABS Earnings Results: $IDXX Reports Quarterly Earnings - Nasdaq
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 EPS $2.96, vs. FactSet Est of $2.85 - marketscreener.com
IDEXX Labs earnings beat by $0.05, revenue fell short of estimates - Investing.com South Africa
IDEXX Laboratories Announces First Quarter Results - TradingView
Watch These 3 MedTech Stocks This Earnings Season: Beat or Miss? - TradingView
Here's How Much $100 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - Yahoo
Animal Health Diagnosis Market Is Booming So Rapidly with IDEXX Laboratories, Zoetis - openPR.com
Earnings Preview: What to Expect From IDEXX Laboratories' Report - MSN
Earnings Preview: What To Expect From IDEXX Laboratories' Report - Barchart.com
Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth US$427 Based On Its Intrinsic Value? - simplywall.st
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
'The Nite Show with Danny Cashman' is Coming to an End - 94.9 HOM
A Look Into IDEXX Laboratories Inc's Price Over Earnings - Benzinga
IDEXX Laboratories Inc (IDXX) Shares Up 3.88% on Apr 22 - GuruFocus
Idexx Laboratories price target lowered to $475 from $535 at BofA - Yahoo Finance
BofA Trims Price Target on IDEXX Laboratories to $475 From $535, Maintains Neutral Rating - marketscreener.com
IDXX Gears Up for Q1 Earnings: What to Expect From the Stock? - MSN
Leerink Partners Adjusts Price Target on IDEXX Laboratories to $500 From $525, Maintains Outperform Rating - marketscreener.com
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - marketscreener.com
Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Amidst Innovation Analysis | IDXX Stock News - GuruFocus
아이덱스 래버러토리스 (IDXX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.46%
자본화:
|
볼륨(24시간):